CVS looks to dismiss hospitals’ 340B lawsuits

CVS Health is attempting to dismiss lawsuits filed by hospital systems in New York and Michigan claiming the company misused savings from the 340B Drug Pricing Program. The company contends these are contract disputes rather than issues under the 340B policy, which restricts drug pricing for certain government-funded entities. This move highlights the ongoing tensions between healthcare providers and pharmacy benefit managers over drug pricing regulations, with broader implications for healthcare cost management and patient access to affordable medications.